15.11 0.00 (0.00%)
After hours: 4:59PM EDT
|Bid||14.00 x 1000|
|Ask||16.25 x 800|
|Day's Range||14.97 - 15.49|
|52 Week Range||5.70 - 19.60|
|Beta (3Y Monthly)||-1.30|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 7, 2018 - Mar 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||16.50|
Both stocks have gained over 140% in the last year alone. Both are looking forward to growth from innovative sweetener ingredients. One doesn't belong in your portfolio.
REDWOOD CITY, Calif., Oct. 01, 2018-- Codexis, Inc., a leading protein engineering company, announces the appointment of Claus Ladefoged as Director, Enzyme Business Development. Ladefoged has extensive ...
The Zacks Analyst Blog Highlights: AeroVironment, BioSpecifics, Codexis, Avid and American Outdoor
There are still winners on the index across industries that are easily surviving the worst start to September and have a solid Zacks Rank #1 (Strong Buy) or 2 (Buy).
For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...
REDWOOD CITY, Calif., Aug. 29, 2018-- Codexis, Inc., a leading protein engineering company, announces that management will present at three upcoming investment conferences:. Wainwright 20 th Annual Global ...
NEW YORK, Aug. 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Codexis, ...
Investors looking for fast-growing stocks in an expensive market might want to follow the lead of Mike Balkin and Ward Sexton, managers of the superstar William Blair Small Cap Growth fund, which has outpaced 94% of small-cap growth funds tracked by Morningstar.
W.W. Grainger (GWW) will gain from its investment in e-commerce and digital capabilities as well as executing supply chain management actions and efforts to strengthen relationships with customers.
Codexis (CDXS) delivered earnings and revenue surprises of 83.33% and 14.09%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The Redwood City, California-based company said it had a loss of 7 cents per share. Losses, adjusted for stock option expense and non-recurring costs, came to 2 cents per share. The producer of custom ...
Total revenues increase 31% to $13.5 million driven by higher R&D revenue. Phase 1 a clinical trial for CDX-6114 initiated. Conference call begins at 4:30 p.m. Eastern time today.
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Codexis, Inc. (NASDAQ: CDXS ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 4:30:00 PM Eastern Time. To ...
REDWOOD CITY, Calif., Aug. 01, 2018-- Codexis, Inc., a leading protein engineering company, announces that it will report second quarter 2018 financial results after market close on Wednesday, August 8, ...
LONDON, UK / ACCESSWIRE / July 6, 2018 / If you want a free Stock Review on CLVS sign up now at www.wallstequities.com/registration. On Thursday, July 05, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. All sectors ended Thursday's trading session in bullish territories.
The world's top lithium producer, a biotech just hitting its stride, and America's top consumer lawn care specialist should be enticing for growth-seeking investors.
Tesla investors have already made a lot of money, and that could continue. But these three stocks could do far better. Here's why.